We have recently developed a clinically relevant mouse model of MTC in which transgenic overexpression of p25-GFP, a cyclin-dependent kinase 5 (Cdk5) activator causes MTC. The gene discussed is CDK5; the disease is medullary thyroid gland carcinoma.